Tag: Omnipod
Insulet sees momentum, raises outlook
May 7, 2026HME News Staff
ACTON, Mass. – Insulet reported revenue of $761.7 million for the first quarter of 2026, an increase of 33.9% over the prior year. Total Omnipod revenue was $758.4 million, up 36.9%. Of that, U.S. Omnipod revenue was $515.6 million and international Omnipod revenue was $242.9 million.
“We started the year strong, delivering continued growth momentum and robust operating margin expansion in the first quarter,” said Ashley McEvoy, president and CEO. “Our team executed on...
In brief: New York’s John Quinlan named Van Miller Homecare Champion
February 20, 2026HME News Staff
WASHINGTON – AAHomecare has announced that John Quinlan is this year’s Van Miller Homecare Champion, recognizing three decades of extraordinary leadership, generosity, spirit of caring and service to the HME community.
Quinn, president and CEO of Quinlan's Pharmacy and Medical Equipment, also has held industry leadership roles, including Chair of the AAHomecare State Leaders Council, service on AAHomecare’s Executive...
Insulet’s Omnipod continues to deliver
February 19, 2026HME News Staff
ACTON, Mass. – Insulet Corporation reported revenue of $783.8 million for the fourth quarter of 2025, an increase of 31% over the same period a year prior and ahead of the company’s guidance in the 25% to 28% range.
Of that, U.S. Omnipod revenue was $567.8 million and international Omnipod revenue was $214 million.
For the full year, Insulet reported revenue of $2.7 billion, an increase of 30.7%, over...
In brief: Medicare comparison legislation, Omnipod expansion, Owlet partnership
February 18, 2026HME News Staff
WASHINGTON — Senator Tim Scott, R-S.C., has introduced the Apples to Apples Comparison Act of 2026, which seeks to require the Centers for Medicare and Medicaid Services (CMS) to provide seniors with clear, comparable data when choosing between Medicare Advantage (MA) and traditional fee-for-service coverage. By giving seniors accurate cost and coverage information, the legislation empowers them to choose the plan that best meets their health care needs. “Seniors...
Insulet’s Omnipod 5 available in Middle East
February 17, 2026HME News Staff
ACTON, Mass. – Insulet’s Omnipod 5 Automated Insulin Delivery (AID) System is now available in the Middle East – including Saudi Arabia, Kuwait, Qatar, and the United Arab Emirates (UAE). “We’re proud to bring Omnipod 5 to a region where the unmet need is great,” said Pat Crannell, senior vice president and international general manager. “These launches build on our significant momentum as we continue to transform the lives of people...
Insulet sees 31% revenue jump
November 10, 2025HME News Staff
ACTON, Mass. – Insulet reported Omnipod revenue of $699.2 million for the third quarter of 2025, up 31% over the same quarter in 2024. Of that, U.S. Omnipod revenue was $497.1 million and International Omnipod revenue was $202.1 million. “We delivered strong third quarter results, a testament to our team’s exceptional performance and the transformative power of Omnipod 5 for people living with diabetes,” said Ashley McEvoy,...
Insulet reports ‘robust’ quarter
August 7, 2025HME News Staff
ACTON, Mass. - Insulet reported revenue of $649.1 million for the second quarter of 2025, up 32.9% compared to the same period last year.
Total Omnipod revenue was $639 million, up 33%. Of that, U.S. Omnipod revenue was $453.2 million, up 28.7%, and international Omnipod revenue was $185.8 million, up 45%. Adjusted EBITDA was $157.5 million.
“We delivered robust second quarter results, reflecting our team’s strong performance and the compelling impact and appeal...
Insulet’s Omnipod integrates with Libre
November 21, 2024HME News Staff
ACTON, Mass. – Insulet’s Omnipod 5 Automated Insulin Delivery System is now compatible with Abbott’s FreeStyle Libre 2 Plus continuous glucose monitoring sensor in the U.S. “We are excited to announce that Omnipod 5, the only AID system indicated for both Type 1 and Type 2 diabetes, is now integrated with Abbott’s FreeStyle Libre 2 Plus sensor in the U.S.,” aid Eric Benjamin, Insulet’s executive vice president and chief product and customer experience officer....
Insulet sees ‘robust’ Q3
November 8, 2024HME News Staff
ACTON, Mass. – Insulet reported revenue of $543.9 million for the third quarter of 2023, an increase of 25.7%. Total Omnipod revenue was $533.6 million, an increase of 26.4%; of that, U.S. Omnipod revenue was $395.6 million and international Omnipod revenue was $138 million. “We continue to achieve significant milestones and robust revenue growth," said Jim Hollingshead, president and CEO. “Omnipod 5 is the first and only automated insulin delivery system in the U.S. for both...
Insulet: ‘2024 is shaping up to be another year of rapid growth’
August 13, 2024HME News Staff
ACTON, Mass. – Insulet has reported revenue of $488.5 million for the second quarter of 2024, a 23.2% increase year over year, exceeding the high end of the company’s guidance, driven by outperformance for all product lines.
Total Omnipod revenue was $480.4 million, a 26.3% increase, including $352.3 million in the U.S., a 27.3% increase.
“2024 is shaping up to be another year of rapid growth, fueled by strong Omnipod 5 demand and our accelerating pace of product...